NASDAQ:NTLA - Intellia Therapeutics, Inc.
$16.15
 $-0.06
-0.37%
4:00PM EDT
2019-04-18
Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that initiates the natural cellular repair process to knockout, repair or insert a gene. The guide RNA sequence recognizes and directs the Cas9 to a specific target deoxyribonucleic acid (DNA) sequence. The Company's sentinel in vivo programs focus on the use of Lipid Nanoparticle (LNPs) for delivery of the CRISPR/Cas9 complex to the liver. The Company's division, eXtellia Therapeutics, is focused on the application of CRISPR/Cas9 genome editing in the fields of immuno-oncology and autoimmune and inflammatory diseases. The Company's subsidiary is Intellia Securities Corp. As of September 30, 2016, the Company had not generated any revenue. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NTLA     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 73   203. 85   241. 91  
42 stocks rank:  3. 60 K 1. 44 K 1. 05 K
# analyst opinions:  7. 00   14. 51   13. 97  
mean recommendation:  2. 10   2. 09   2. 01  

quick ratio:  7. 93   5. 27   1. 81  
current ratio:  8. 01   5. 62   2. 25  

target price low:  19. 00   84. 80   115. 21  
target price avg:  31. 79   111. 51   137. 51  
target price high:  18. 30   135. 81   157. 84  
1-yr high:  32. 60   114. 23   138. 78  
last close:  16. 15   87. 66   116. 69  
50-day avg:  16. 00   95. 54   123. 44  
200-day avg:  20. 64   94. 25   121. 11  
1-yr low:  11. 39   72. 78   98. 34  
volume:  484. 19 K 4. 11 M 8. 07 M
50-day avg volume:  592. 53 K 2. 76 M 5. 02 M
200-day avg volume:  625. 63 K 2. 92 M 4. 59 M

1-day return:  -0. 37 % -0. 41 % 0. 07 %
this week return:  -5. 17 % -5. 74 % -4. 11 %
12-wk return:  9. 42 % 1. 61 % -0. 05 %
52-wk return:  -20. 34 % 3. 12 % 8. 78 %

enterprise value (EV):  416. 33 M 48. 94 B 114. 64 B
market cap:  730. 89 M 43. 07 B 104. 73 B
EBITDA:  -86. 41 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -4. 82   4. 22   12. 73  
enterprise/revenue (EV/R):  13. 68   63. 17   12. 84  
total revenue:  30. 43 M 10. 62 B 38. 47 B
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -85. 34 M 2. 20 B 4. 20 B

shares outstanding:  45. 26 M 571. 70 M 1. 24 B
shares:  35. 04 M 571. 81 M 1. 23 B
shares short:  8. 01 M 10. 17 M 13. 00 M
shares short prior month:  7. 92 M 9. 54 M 17. 33 M
short ratio:  12. 84   5. 41   3. 28  
short % of float:  20. 01 % 5. 45 % 2. 38 %
total cash/share:  6. 94   11. 14   9. 33  
total cash:  314. 06 M 6. 71 B 7. 15 B
free cash flow:  -29. 19 M 3. 58 B 2. 96 B
operating cash flow:  -61. 26 M 4. 15 B 4. 30 B

book value:  6. 14   12. 78   26. 92  
price/book:  2. 63   3. 06   -1. 74  
gross profits:  -58. 68 M 8. 04 B 34. 86 B
operating margins:  -298. 58 % -725. 35 % -89. 04 %
EBITDA margins:  -283. 91 % 10. 94 % 22. 51 %
profit margins:  -280. 42 % 7. 81 % 10. 57 %
gross margins:  -192. 81 % 37. 08 % 55. 70 %

1-yr max volatility:  -16. 98 % --- ---
1-yr mean volatility:  -0. 03 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 98   2. 40   4. 10  
forward EPS:  -2. 86   3. 97   7. 13  
P/E:  -8. 15   13. 63   22. 72  
forward P/E:  -5. 65   -15. 95   13. 99  
PE/G:  -0. 45   -1. 65   -1. 32  
growth:  18. 20 % 127. 12 % 29. 61 %
earnings high:  -0. 48   1. 00   1. 66  
earnings avg:  -0. 58   0. 77   1. 53  
earnings low:  -0. 78   0. 50   1. 39  
revenue high:  10. 63 M 2. 68 B 10. 78 B
revenue avg:  7. 63 M 2. 59 B 10. 57 B
revenue low:  5. 00 M 2. 49 B 10. 36 B
return on assets:  -15. 70 % -2. 75 % 4. 55 %
return on equity:  -29. 50 % -18. 45 % 5. 46 %
revenue growth:  18. 20 % 92. 86 % 18. 96 %
revenue/share:  0. 71   13. 29   55. 46  

beta (1yr vs S&P500):  2. 20   1. 25   0. 93  
sharpe (1yr):  -0. 09   0. 37   0. 70  

held % insiders:  22. 51 % 6. 39 % 3. 38 %
held % institutions:  71. 58 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : NTLA
.    + 2.037 =         2.037 :: INITIAL WEIGHT
.   + 32.877 =        34.914 :: inverse volume-to-price addition
.   + 37.417 =        72.331 :: spline projection addition
.    x 3.736 =       270.205 :: 13 weeks' performance factor
.    x 0.837 =       226.134 :: one-year gains+dividend factor
.    x 1.431 =       323.694 :: industry recommendation factor
.    x 2.055 =       665.317 :: symbol recommendation factor
.    x 1.217 =       809.385 :: EV/R factor
.    x 0.998 =       808.115 :: return on assets factor
.    x 0.997 =        805.73 :: return on equity factor
.    x 2.301 =      1853.982 :: revenue growth factor
.    x 2.576 =      4775.501 :: current ratio factor
.     x 1.07 =      5108.587 :: quick ratio factor
.    x 1.038 =       5303.79 :: short ratio factor
.    x 2.026 =     10746.972 :: price-to-book factor
.    x 1.045 =     11235.819 :: 5-day avg > 50-day avg
.    x 2.022 =     22717.256 :: P/E weight
.    x 1.223 =     27771.959 :: PE/G factor
.    x 1.282 =      35591.32 :: beta factor
.    x 0.093 =      3298.182 :: sharpe factor
.    x 1.431 =      4721.303 :: target low factor
.    x 1.328 =      6270.023 :: target mean factor
.    x 1.037 =      6498.944 :: target high factor
.     x 1.31 =      8512.888 :: industry 2-weeks return factor
.    x 0.993 =      8457.226 :: "drift" penalty 3 days ago
.    x 0.907 =      7672.803 :: "drift" penalty 4 days ago
.    x 0.952 =      7308.029 :: overall "drift" factor
.    x 0.999 =      7302.814 :: largest single-day jump factor
.    x 0.971 =      7090.108 :: low price factor
.      x 1.0 =      7088.957 :: factor hist industry gain for week 16
.   cubeRoot =         19.21 :: reduced to standardize
.   - 23.331 =         0.727 :: add/subtract for performance
.                      0.727 :: FINAL WEIGHT for NASDAQ:NTLA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org